Global Budesonide Market Data Survey Report 2025
- HEY1469603
- 77 Pages
- August 2017
- Pharmaceuticals
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and nasal spray.The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis.
The global Budesonide market will reach xxx Million USD in 2017 with CAGR xx% from 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical
Major applications as follows:
Respiratory disease treatment
Nose disease treatment
Inflammatory bowel disease treatment
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 AstraZeneca
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Cosmo Pharmaceuticals
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Teva
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Mylan
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Sandoz
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Dr. Falk Pharma
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Chiesi Farmaceutici S.p.A
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Orion Corporation
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Cipla
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Synmosa Biopharma Corporation
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Lunan Better Pharmaceutical
3.12 Shanghai Sine Promod Pharmaceutical
4 Major Application
4.1 Respiratory disease treatment
4.1.1 Overview
4.1.2 Respiratory disease treatment Market Size and Forecast
4.2 Nose disease treatment
4.2.1 Overview
4.2.2 Nose disease treatment Market Size and Forecast
4.3 Inflammatory bowel disease treatment
4.3.1 Overview
4.3.2 Inflammatory bowel disease treatment Market Size and Forecast
5 Market Price
5.1 Overview
5.2 Price by SUK
6 Conclusion
List Of Tables
Tab Regional Production 2011-2017 (Value)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Tab Sales Revenue, Volume, Price, Cost and Margin of Cosmo Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva
Tab Sales Revenue, Volume, Price, Cost and Margin of Mylan
Tab Sales Revenue, Volume, Price, Cost and Margin of Sandoz
Tab Sales Revenue, Volume, Price, Cost and Margin of Dr. Falk Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Chiesi Farmaceutici S.p.A
Tab Sales Revenue, Volume, Price, Cost and Margin of Orion Corporation
Tab Sales Revenue, Volume, Price, Cost and Margin of Cipla
Tab Sales Revenue, Volume, Price, Cost and Margin of Synmosa Biopharma Corporation
Tab Sales Revenue, Volume, Price, Cost and Margin of Lunan Better Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Shanghai Sine Promod Pharmaceutical
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Budesonide Market Size and CAGR 2011-2017 (Value)
Fig Global Budesonide Market Size and CAGR 2011-2017 (Volume)
Fig Global Budesonide Market Forecast and CAGR 2018-2025 (Value)
Fig Global Budesonide Market Forecast and CAGR 2018-2025 (Volume)
Fig Respiratory disease treatment Market Size and CAGR 2011-2017 (Value)
Fig Respiratory disease treatment Market Size and CAGR 2011-2017 (Volume)
Fig Respiratory disease treatment Market Forecast and CAGR 2018-2025 (Value)
Fig Respiratory disease treatment Market Forecast and CAGR 2018-2025 (Volume)
Fig Nose disease treatment Market Size and CAGR 2011-2017 (Value)
Fig Nose disease treatment Market Size and CAGR 2011-2017 (Volume)
Fig Nose disease treatment Market Forecast and CAGR 2018-2025 (Value)
Fig Nose disease treatment Market Forecast and CAGR 2018-2025 (Volume)
Fig Inflammatory bowel disease treatment Market Size and CAGR 2011-2017 (Value)
Fig Inflammatory bowel disease treatment Market Size and CAGR 2011-2017 (Volume)
Fig Inflammatory bowel disease treatment Market Forecast and CAGR 2018-2025 (Value)
Fig Inflammatory bowel disease treatment Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
